Neurogenesis After Stroke: A Therapeutic Perspective

Transl Stroke Res. 2021 Feb;12(1):1-14. doi: 10.1007/s12975-020-00841-w. Epub 2020 Aug 29.

Abstract

Stroke is a major cause of death and disability worldwide. Yet therapeutic strategies available to treat stroke are very limited. There is an urgent need to develop novel therapeutics that can effectively facilitate functional recovery. The injury that results from stroke is known to induce neurogenesis in penumbra of the infarct region. There is considerable interest in harnessing this response for therapeutic purposes. This review summarizes what is currently known about stroke-induced neurogenesis and the factors that have been identified to regulate it. Additionally, some key studies in this field have been highlighted and their implications on future of stroke therapy have been discussed. There is a complex interplay between neuroinflammation and neurogenesis that dictates stroke outcome and possibly recovery. This highlights the need for a better understanding of the neuroinflammatory process and how it affects neurogenesis, as well as the need to identify new mechanisms and potential modulators. Neuroinflammatory processes and their impact on post-stroke repair have therefore also been discussed.

Keywords: Cytokines; Neurogenesis; Neuroinflammation; Stroke; Stroke therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Brain / cytology
  • Brain / pathology
  • Brain / physiology
  • Brain Ischemia / pathology*
  • Brain Ischemia / therapy
  • Humans
  • Neurogenesis / drug effects
  • Neurogenesis / physiology*
  • Neuroprotective Agents / administration & dosage
  • Recovery of Function / physiology*
  • Stem Cell Transplantation / trends
  • Stroke / pathology*
  • Stroke / therapy

Substances

  • Neuroprotective Agents